Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 261-819-9 | CAS number: 59587-44-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
There are no data available for the genetic toxicity of 2 -ethylhexyl nonanoate (CAS 59587 -44 -9). In order to fulfil the standard information requirements set out in Annex VIII, 8.4, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006, read-across from structurally related substances was conducted.
In accordance with Article 13 (1) of Regulation (EC) No 1907/2006, "information on intrinsic properties of substances may be generated by means other than tests, provided that the conditions set out in Annex XI are met.” In particular for human toxicity, information shall be generated whenever possible by means other than vertebrate animal tests, which includes the use of information from structurally related substances (grouping or read-across).
Having regard to the general rules for grouping of substances and read-across approach laid down in Annex XI, Item 1.5, of Regulation (EC) No 1907/2006 whereby substances may be predicted as similar provided that their physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity.
Overview for genetic toxicity
CAS # |
Genetic toxicity (mutagenicity) in bacteria in-vitro |
Genetic toxicity (cytogenicity) in mammalian cells in-vitro |
Genetic toxicity (mutagenicity) in mammalian cells in-vitro |
Genetic toxicity in vivo |
59587-44-9 Target substance |
RA: 135800-37-2 RA: 163961-32-8 |
RA: 10233-13-3 RA: 26399-02-0 |
RA: 10233-13-3 RA: 26399-02-0 |
RA: 135800-37-2 |
10233-13-3 |
-- |
negative |
negative |
-- |
163961-32-8 |
negative |
-- |
-- |
-- |
135800-37-2 |
negative |
-- |
-- |
negative |
26399-02-0 |
-- |
negative |
negative |
-- |
The above mentioned substance is considered to be similar on the basis of structural similarity resulting in similar properties and/or activities. The available endpoint information is used to predict the same endpoints for 2-ethylhexyl nonanoate (CAS 59587-44-9).
A detailed analogue approach justification is provided in the technical dossier (see IUCLID Section 13).
Discussion:
CAS 135800-37-2
AMES, OECD 471, negative
The mutagenic potential of Fatty acids, C8-16, 2-Ethylhexyl Esters (CAS# 135800-37-2) was tested in a Salmonella typhimurium reverse mutation assay equivalent to OECD Guideline 471 and under GLP (Banduhn, 1990). The following strains were used: TA 1535, TA 1537, TA 1538, TA 98 and TA 100. Tester strains were incubated with test material concentrations of 0, 8, 40, 200, 100 and 5000 µg/plate in Tween 80/bidest water with and without the addition of a metabolic activation system (Aroclor 1254 induced rat liver S9 mix). 4-Nitro-o-phenylendiamine, Sodium Azide and 9-Aminoacridine and 2-Aminoanthracene were used as positive controls without and with S9 mix, respectively. Two independent experiments were performed with triplicates each. No toxicity of the test substance was observed.
Positive control materials induced statistically significant increases in the frequency of revertant colonies indicating the satisfactory performance of the test and the activity of the metabolizing system. No increase in the frequency of revertant colonies compared to concurrent negative controls was observed in all strains tested, neither in the presence nor in the absence of metabolic activation. Thus, Fatty acids, C8-16, 2-Ethylhexyl Esters did not induce point mutations by base-pair changes or frame-shifts in the genome of the strains used.
Micronucleus Test in vivo, OECD 474, negative
The ability to induce chromosome aberrations in vivo in mouse bone marrow cells was tested according to OECD guideline 474 and GLP (Paika, 1991). Male and female mice were treated with 0, 1075, 2150 and 4300 mg/kg bwFatty acids, C8-16, 2-Ethylhexyl Esters (CAS# 135800-37-2)by single intraperitoneal injection and sacrificed for examination at 24 h intervals for up to 72 hours. Cyclophosphamide was used as a positive control. The mouse micronucleus test did not reveal increases in the frequency of micronucleated polychromatic erythrocytes inFatty acids, C8-16, 2-Ethylhexyl Esterstreated animals and therefore no indications of induced chromosome damage were found.
CAS 163961-32-8
AMES, OECD 471, negative
The mutagenic potential of Fatty acids, C16-18 and C18 unsaturated, branched and linear, Butyl Esters (CAS# 163961-32-8) was tested in a Salmonella typhimurium reverse mutation assay equivalent to OECD Guideline 471 and under GLP (Bowles, 2002). The following strains were used: TA 1535, TA 1537, TA 100, TA 98 and TA 102. Test substance concentrations of 50, 150, 500, 1500 and 5000 µg/plate in acetone were tested in two separate experiments with and without S9 mix. A globular, oily, opaque precipitate was observed at 5000 µg/plate, but this did not inhibit the scoring of revertant colonies. Cytotoxicity was not observed.2-Aminoanthracene, Benzo(a)pyrene and 1,8 Dihydroxyanthraquinone were used as positive controls with S9 mix, whereas N-ethyl-N'-nitro-N-nitrosoguanidine, Mitomycin C, 4-Nitroquinoline-1-oxide and 9-Aminoacridine were tested as positive controls without S9 mix. No increase in the frequency of revertant colonies compared to concurrent negative controls was observed in all strains tested, neither in the presence nor in the absence of metabolic activation. Thus, Fatty acids, C16-18 and C18 unsaturated, branched and linear, Butyl Esters did not induce point mutations by base-pair changes or frame-shifts in the genome of the strains used.
CAS 10233-13-3
In vitro mammalian chromosome aberration test, OECD 473, negative
An in vitro mammalian chromosome aberration test was performed with Isopropyl Laurate (CAS# 10233-13-3) in primary human lymphocytes according to OECD Guideline 473 and GLP (Buskens, 2010). Duplicate cultures of human lymphocytes were evaluated for chromosome aberrations in the presence and absence of metabolic activation (rat liver S9-mix).
In the first experiment cells were exposed for 3 hours to test substance concentrations of 10, 33 and 100 µg/mL in ethanol with and without metabolic activation. In the second experiment cells were exposed for 24 hours to 66, 150 and 250 µg/mL followed by 24 hours expression time. Additionally, 3, 125 and 150 µg/mL were the concentrations used for 48 hours exposure followed by 48 hours expression time. Both incubations were done without metabolic activation.
250 µg/mL was chosen as maximum dose due to limited solubility. Mitomycin C and Cyclophosphamide were used as positive control substances. Vehicle (solvent) controls induced aberration frequencies within the range expected for normal human lymphocytes. Positive control materials induced statistically significant increases in aberration frequencies indicating the satisfactory performance of the test and of the activity of the metabolizing system. Evaluation of 100 well-spread metaphase cells from each culture for structural chromosomal aberrations revealed no increase in the frequency of chromosome aberrations and polyploid cells at any dose level in comparison to the negative controls. The test material demonstrated only modest cytotoxicity. The test material was therefore considered to be non-clastogenic to human lymphocytes in vitro.
In vitro mammalian cell gene mutation test, OECD 476, negative
An in vitro Mammalian Cell Gene Mutation Assay according to OECD Guideline 476 and GLP was performed with Isopropyl Laurate (CAS# 10233-13-3) in mouse lymphoma L5178Y cells (Verspeek-Rip, 2010). The cells were treated for 3 and 24 hours with 8% (v/v) and without S9-mix and with 12% (v/v) and without S9-mix, respectively. The test substance was tested up to precipitation, the following concentrations were tested: 0.01, 0.03, 0.1, 0.3, 1, 3, 5 and 10μg/mL. Cyclophosphamide and Methylmethanesulfonate were used as positive controls with and without S9 mix, respectively. No toxicity was observed and all dose levels were evaluated in the absence and presence of S9-mix. Positive and negative controls were valid and in range of historical control data.No significant increase in the mutation frequency at the TK locus was observed after treatment with Isopropyl Laurate either in the absence or in the presence of S9-mix. The numbers of small and large colonies in the Isopropyl Laurate treated cultures were comparable to the numbers of small and large colonies of the solvent controls. It was concluded that Isopropyl Laurate is not mutagenic in the mouse lymphoma L5178Y test system under the experimental conditions described.
CAS 26399-02-0
In vitro mammalian chromosome aberration test, OECD 473, negative
An in vitro mammalian chromosome aberration test was performed with 2 -Ethylhexyl oleate (CAS# 26399 -02 -0) in primary human lymphocytes according to OECD Guideline 473 and GLP (Buskens, 2010). Duplicate cultures of human lymphocytes were evaluated for chromosome aberrations in the presence and absence of metabolic activation (rat liver S9-mix).
In the first experiment cells were incubated with test substance concentrations of 3, 10 and 33 µg/mL in ethanol for 3 hours with and without metabolic activation. In the second experiment cells were incubated with 3, 10 and 33 µg/mL for 24 hours followed by 24 hours expression time and 48 hours following 48 hours expression time without S9. 33 µg/mL was chosen as maximum dose due to limited solubility of the test substance. Mitomycin C and Cyclophosphamide were used as positive control substances. Evaluation of 100 well-spread metaphase cells from each culture for structural chromosomal aberrations revealed no increase in the frequency of chromosome aberrations and polyploid cells at any dose level in comparison to the negative controls. The test material demonstrated only modest cytotoxicity. Vehicle (solvent) controls had frequencies of cells with aberrations within the range expected for normal human lymphocytes. Positive control materials induced statistically significant increases in the frequency of cells with aberrations indicating the satisfactory performance of the test and of the activity of the metabolizing system. The test material did not induce a statistically significant increase in the frequency of cells with chromosome aberrations in either the absence or presence of a liver enzyme metabolizing system in either of two separate experiments. The test material was therefore considered to be non-clastogenic to human lymphocytes in vitro.
In vitro mammalian cell gene mutation test, OECD 476, negative
An in vitro Mammalian Cell Gene Mutation Assay according to OECD Guideline 476 and under GLP was performed with 2-Ethylhexyl Oleate (CAS# 26399-02-0) in mouse lymphoma L5178Y cells (Verspeek-Rip, 2010). Two independent experiments (with 3 or 24 hours of exposure) were performed in the absence and presence of S9-mix with test substance concentrations up to 100μg/mL dissolved in ethanol. Precipitation was seen at 100µg/mL and higher. Cyclophosphamide and Methylmethanesulfonate were used as positive controls with and without S9 mix, respectively. Positive and negative controls were valid and in range of historical control data. No significant increase in mutation frequency occurred in any of the test conditions, indicating that 2-Ethylhexyl Oleate is not mutagenic in the mammalian cells in vitro.
Conclusion for genetic toxicity
Two studies assessing the potential genetic toxicity using analogue based read-across from structure related substances Fatty acids, C8-16, 2-Ethylhexyl Esters (CAS 135800-37-2) and Fatty acids, C16-18 and C18 unsaturated, branched and linear, Butyl Esters (CAS 163961-32-8) in bacteria (Ames test) were available. In vitro chromosomal aberration tests were performed with 2 -Ethylhexyl oleate (CAS 26399-02-0) and Isopropyl Laurate (CAS 10233-13-3). Two in vitro mammalian cell gene mutation assays were also available with 2-ethylhexyl oleate (CAS 26399-02-0) and Isopropyl Laurate (CAS 10233-13-3). The in vivo mammalian erythrocyte micronucleus test in bone marrow was performed with Fatty acids, C8-16, 2-ethylhexyl esters (CAS 135800-37-2). The results of all the tests were negative. The available data on genetic toxicity, both in vitro and in vivo, indicates that the structural related substances do not have genetic toxicity potential.
Justification for selection of genetic toxicity endpoint
Hazard assessment is conducted by means of read-across based on an analogue approach. No study was selected since all available in vitro and in vivo genetic toxicity studies were negative. All available studies are adequate and reliable based on the identified similarities in structure and intrinsic properties between source and target substance and overall quality assessment (refer to the endpoint discussion for further details).
Short description of key information:
Negative results in several Salmonella typhimurium strains , with and without metabolic activation (OECD 471, GLP, analogue approach).
Negative results in mammalian chromosomal aberration test (OECD 473, GLP, analogue approach).
Negative results in mammalian cell gene mutation tests (OECD 476, GLP, analogue approach).
Negative results in in vivo micronucleus test (OECD 474, GLP, analogue approach).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on read-across from structurally similar substances, the available data on genetic toxicity do not meet the classification criteria according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.